Gates Foundation allots $120 mln for poor nations to get COVID-19 drug

Gates Foundation to spend $120M on access for COVID-19 pill

The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators

Gates Foundation to spend $120M on access for COVID-19 pill

By HALELUYA HADERO AP Business WriterThe Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators. The private foundation says it will use the funds to “support the range of activities required to develop and manufacture generic versions” of the drug, molnupiravir. The foundation says it ha…

Gates Foundation to spend $120M on access for COVID-19 pill

The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators.

Gates Foundation commits up to $120M to support access to new COVID-19 pill

The Bill & Melinda Gates Foundation will provide up to $120 million to help lower-income countries access a new pill to treat COVID-19, the foundation announced Tuesday. Molnupiravir cuts the risk of…

Merck’s Covid-19 drug could get to poorer nations within months

The Bill and Melinda Gates Foundation is kicking in as much as $120m to widen global access to the therapy

Bill & Melinda Gates Foundation To Donate $120M To COVID-19 Pill Development

The foundation donation is earmarked to support the development and manufacture of a generic version of the COVID-19 drug